Pediatrics

Treatment resistance is an emerging challenge requiring pharmacists to employ evidence-based strategies.

Get the info you need on this new products, part of our drug news roundup for April.

The first needle-free epinephrine treatment for severe allergic reactions could be on the market in Canada as soon as this summer.

Which statement about Jornay PM, a new formulation of methylphenidate for the treatment of attention-deficit hyperactivity disorder, is FALSE?

A study found an average 3.5% increase every year in self-injuries over 24 years documented in hospital and doctor’s visits, with higher rates among girls than boys.

Canadian researchers looked at link between generalized anxiety disorder, major depressive disorder and suicidality and cannabis use.

Most of us come into contact with the ‘pure’ metals that aren’t supposed to cause allergic reactions—but things aren’t always so simple.

Last year, U.S. President Donald Trump told pregnant women not to take Tylenol as he promoted unproven ties between the fever reducer and autism and touted an old generic drug as a treatment for the developmental condition.